Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant epithelial ovarian cancer (PR-EOC): A CTEP-sponsored phase II study Meeting Abstract


Authors: Hensley, M. L.; Kravetz, S.; Sima, C.; Tew, W.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C. A.; Zarwan, C.; Berlin, S.
Abstract Title: Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant epithelial ovarian cancer (PR-EOC): A CTEP-sponsored phase II study
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 292s
Language: English
ACCESSION: WOS:000276606600062
PROVIDER: wos
Notes: Meeting Abstract: 5561 -- Source: Wos
MSK Authors
  1. Camelia S Sima
    204 Sima
  2. Paul J Sabbatini
    199 Sabbatini
  3. Martee L Hensley
    220 Hensley
  4. William P Tew
    122 Tew
  5. Christine Allison Whalen
    1 Whalen